Oral |
Tablets |
|
Low patient adherence
Extended release is difficult to achieve
Solubility and absorption challenges
Low gastric retention time
Significant first-pass metabolism
|
|
Parenteral |
Implants Injectables |
Sustained drug release
Compatible with many APIs
Injections are most accepted and have the highest adherence by South African women
Does not interfere with daily activities
Tunable system
|
Invasive surgery or large needles
Implants need to be inserted or removed
Injection site reactions
Difficulties with reversibility or immediate withdrawal of the drug(s)
Typically needs to be administered by a provider
|
Biodegradable materials
Reversible or removable
|
Vaginal |
Films Gels Tablets/Inserts |
|
Extended release is difficult to achieve
Difficulties with vaginal bioadhesion
May interfere with daily activities
Effectiveness is dependent on user adherence
|
|
Intravaginal rings |
Sustained drug release
Tunable release kinetics
Compatible with many APIs
Significant drug uptake and absorption
No need for pre-coitus action
|
Incomplete API release
May interfere with intercourse
Low user acceptability
Limited material and design choices
One size/one dose does not fit all
Possibility of expulsion
|
|